Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | Perspectives: current and future treatment landscape for Alzheimer’s

Carol Routledge, PhD, Director of Research at Alzheimer’s Research UK (ARUK), Cambridge, UK, who has a background in neuropharmacology, discussed with us her perspective on current and future treatments and therapy research for Alzheimer’s. Speaking at the ARUK Conference 2019, held in Harrogate, UK, Dr Routledge goes on to discuss what can be done to impove drug development.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.